Vaccines: A Savior From New Castle Disease

The team, which includes Steven Stice and Franklin West in the College of Agricultural and Environmental Sciences and Claudio Afonso at the Southeast Poultry Research Laboratory of the US Department of Agriculture's Agricultural Research Service, used a technology platform called shRNA - single strands of RNA that fold back on themselves - to selectively stop the production of nucleic acids that cause disease, such as the Newcastle disease virus. Newcastle disease is a worldwide problem and is caused by one of the most deadly of all viruses that spreads between birds. Exotic Newcastle virus, the most devastating form of the virus, has been eradicated in the US and Canada. The milder forms of Newcastle are kept under control using vaccines.

This news is certainly a ray of home for the farm animal breeders and owners. Newcastle disease is said to be most devastating devil who has taken lives of many animals in the past and still hunts these speechless living bodies. Presently, there are vaccines for diseases such as anthrax, influenza, rabies etc. Since recent past, the vet vaccine market has gained significant pace and research is this area has also got intense. The market in the year 2014 amounted to $12.68 billion and is expected to reach a value of US$19.35 billion by 2019 with a CAGR of 8.84 %. Increasing Incidence of Zoonotic and Airborne diseases is a major driving factor for the growth of the veterinary vaccine market. World Health Organization estimates that in more than 100 countries and territories, rabies is one of the most prevalent Zoonotic diseases. Rabies in dogs is the source of 99% of human infections and poses a potential threat to more than 3.3 billion people, primarily in Asia and Africa. During the last two decades, 75 percent of emerging diseases affecting humans occurred as a consequence of an animal pathogen migrating into a human host.

Global veterinary vaccines comprise approximately 23% of the global animal health market. The most successful animal health vaccines enjoy a combined market size of 10 to 20% of $ 1 billion market. Asia Pacific is amongst the top five markets which held about $1.2 billion dollars in the year 2014 and is expected to mark $1.7 billion by the end of 2020.

Now with the addition of the new castle disease mentioned in the beginning, the vaccine market is expected to become even bigger in terms of size and this new offering would prove to be a sigh of relief for the animals first and then their owners.

We specialize in Market Research Consulting, Market Research Reports, Market Sizing Reports, Industry Research Reports, Global Strategic Business Reports etc.